Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

被引:29
|
作者
Marshall, Katherine L. [1 ]
Farah, Mohamed H. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
amyotrophic lateral sclerosis; axonal regeneration; dying-back axonopathy; in vitro neuromuscular junction; iPSC-derived motor neurons; microfluidic device; motor axon sprouting; AMYOTROPHIC-LATERAL-SCLEROSIS; TERMINAL SCHWANN-CELLS; PLACEBO-CONTROLLED TRIAL; NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE; MOTOR-NEURONS; SPINAL-CORD; MOUSE MODEL; MOLECULAR-MECHANISMS; HUNTINGTONS-DISEASE;
D O I
10.4103/1673-5374.308077
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.
引用
收藏
页码:1901 / 1910
页数:10
相关论文
共 50 条
  • [21] Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage
    Tan, Hai-Bo
    Zhong, Yi-Sheng
    Cheng, Yu
    Shen, Xi
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (06) : 652 - 657
  • [22] VGF: A prospective biomarker and therapeutic target for neuroendocrine and nervous system disorders
    Wang, Yibei
    Qin, Xiaoxue
    Han, Yun
    Li, Bo
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
  • [23] ABCA2 as a therapeutic target in cancer and nervous system disorders
    Mack, Jody T.
    Brown, Carol B.
    Tew, Kenneth D.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (04) : 491 - 504
  • [25] MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
    Wen-Hao Zhang
    Lian Jiang
    Mei Li
    Jing Liu
    Experimental Brain Research, 2023, 241 : 1215 - 1226
  • [26] Lin28 as a therapeutic target for central nervous system regeneration and repair
    Shuo Wang
    Shuxin Li
    Neural Regeneration Research, 2024, 19 (02) : 397 - 398
  • [27] Lin28 as a therapeutic target for central nervous system regeneration and repair
    Wang, Shuo
    Li, Shuxin
    NEURAL REGENERATION RESEARCH, 2024, 19 (02) : 397 - 398
  • [28] Axonal regeneration as a therapeutic target toward Parkinson's disease
    Inoue, Haruhisa
    Takahashi, Ryosuke
    Ling, Lin
    Sha, Mi
    Isacson, Ole
    NEUROSCIENCE RESEARCH, 2008, 61 : S7 - S7
  • [29] Axonal growth therapeutics: regeneration or sprouting or plasticity?
    Cafferty, William B. J.
    Mcgee, Aaron W.
    Strittmatter, Stephen M.
    TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 215 - 220
  • [30] PRIOR COLLATERAL SPROUTING ENHANCES AXONAL REGENERATION
    SPARROW, JR
    GRAFSTEIN, B
    BRAIN RESEARCH, 1983, 269 (01) : 133 - 136